Aspen Aerogels, Inc. (NYSE:ASPN) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have received a consensus recommendation of “Hold” from the six analysts that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $5.1875.

Several equities research analysts have recently weighed in on ASPN shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Friday, March 27th. Wall Street Zen upgraded Aspen Aerogels from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. TD Cowen lowered their price objective on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Roth Mkm reiterated a “buy” rating and issued a $5.75 price objective on shares of Aspen Aerogels in a research note on Friday, May 8th. Finally, Barclays upped their price objective on Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a research note on Monday, May 11th.

Aspen Aerogels Trading Down 0.1%

Aspen Aerogels stock opened at $5.64 on Thursday. The business has a 50 day moving average price of $4.53 and a two-hundred day moving average price of $3.73. The company has a quick ratio of 2.54, a current ratio of 2.89 and a debt-to-equity ratio of 0.32. The stock has a market cap of $467.03 million, a price-to-earnings ratio of -4.14 and a beta of 3.02. Aspen Aerogels has a 12 month low of $2.30 and a 12 month high of $9.78.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Thursday, May 7th. The construction company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.01). Aspen Aerogels had a negative net margin of 48.64% and a negative return on equity of 22.16%. The firm had revenue of $37.88 million during the quarter, compared to analyst estimates of $36.58 million. During the same period last year, the company earned ($0.06) EPS. The company’s revenue was down 51.8% on a year-over-year basis. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. As a group, equities analysts forecast that Aspen Aerogels will post -0.8 EPS for the current year.

Institutional Investors Weigh In On Aspen Aerogels

Several large investors have recently modified their holdings of ASPN. Invesco Ltd. grew its stake in shares of Aspen Aerogels by 237.9% in the 4th quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock valued at $11,688,000 after purchasing an additional 2,907,558 shares during the period. Needham Investment Management LLC grew its stake in shares of Aspen Aerogels by 26.5% in the 4th quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company’s stock valued at $12,315,000 after purchasing an additional 912,000 shares during the period. JPMorgan Chase & Co. grew its position in Aspen Aerogels by 105.4% during the 2nd quarter. JPMorgan Chase & Co. now owns 1,246,506 shares of the construction company’s stock worth $7,379,000 after acquiring an additional 639,753 shares during the last quarter. Goldman Sachs Group Inc. grew its position in Aspen Aerogels by 89.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after acquiring an additional 602,586 shares during the last quarter. Finally, Peregrine Investment Management Inc. bought a new stake in Aspen Aerogels during the 3rd quarter worth approximately $4,176,000. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.